Elsevier copyright form pdf

0

Enter your login details below. If you do not already have an account you will elsevier copyright form pdf to register here. Once production of your article has started, you can track the status of your article via Track Your Accepted Article.


The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years. SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.

SJR is a prestige metric based on the idea that not all citations are the same. This application allows readers to explore NCBI data on author-tagged genes through an interactive genetic sequence viewer that supports flipping strands, zooming to a sequence, selecting a specific position, and more.

This application lets readers explore data and other quantitative results submitted with the article, providing insights into and access to data that is otherwise buried in plots. This application allows readers to interactively explore high-resolution slide images using a “Virtual Microscope”.

Publishing your article with us has many benefits, such as having access to a personal dashboard: citation and usage data on your publications in one place. This free service is available to anyone who has published and whose publication is in Scopus. Biomaterials is an international journal covering the science and clinical application of biomaterials.

Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used.

These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering. Click here for New Editorial Instructions.

We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. The most downloaded articles from Biomaterials in the last 90 days.

The most cited articles published since 2012, extracted from Scopus. The latest Open Access articles published in Biomaterials. This journal is now partnering with Heliyon, an open access journal from Elsevier publishing quality peer reviewed research across all disciplines.

Partner journals provide authors with an easy route to transfer their research to Heliyon. Below is a recent list of 2017 articles that have had the most social media attention. The Plum Print next to each article shows the relative activity in each of these categories of metrics: Captures, Mentions, Social Media and Citations. Go here to learn more about PlumX Metrics.

Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds. Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds.

Share.

About Author